Download PDF
Semin Thromb Hemost 2012; 38(07): 652-660
DOI: 10.1055/s-0032-1326781
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Perioperative Management of Patients Having Noncardiac Surgery Who Are Receiving Anticoagulant or Antiplatelet Therapy: An Evidence-Based but Practical Approach

Saeed Darvish-Kazem
1   Department of Medicine, McMaster University, Internal Medicine Residency Office, Hamilton, Ontario, Canada
,
James D. Douketis
2   Department of Medicine, McMaster University and St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada
› Author Affiliations
Further Information

Publication History

Publication Date:
03 October 2012 (online)

    Permissions and Reprints

Abstract

Patients receiving anticoagulant or antiplatelet therapy who require noncardiac surgery represent a common yet challenging clinical problem. Clinicians must balance the risk of thromboembolic and major adverse cardiovascular events that are associated with interrupting these therapies, against the risk of bleeding from continuing these drugs in the perioperative period. Identifying patients at highest risk for such complications requires particular attention to the role of bridging therapy and the optimal timing and duration of drug withdrawal and resumption with surgery. Patients with coronary stents represent a population that requires specific considerations, due to the added risk and significant mortality associated with perioperative stent thrombosis. Minimizing this risk is dependent on several patient- and stent-specific factors. This review provides clinicians with a summary of the available evidence to facilitate a practical approach to the management of these patients while highlighting the need for continued research in this field.

Keywords

perioperative - antiplatelet - anticoagulant - noncardiac surgery - bridging anticoagulation
 

  • References

  • 1 Weiser TG, Regenbogen SE, Thompson KD , et al. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet 2008; 372 (9633) 139-144
    CrossrefPubMedGoogle Scholar
  • 2 Spyropoulos AC, Bauersachs RM, Omran H, Cohen M. Periprocedural bridging therapy in patients receiving chronic oral anticoagulation therapy. Curr Med Res Opin 2006; 22 (6) 1109-1122
    CrossrefPubMedGoogle Scholar
  • 3 Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010; 137 (2) 263-272
    CrossrefPubMedGoogle Scholar
  • 4 Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001; 285 (22) 2864-2870
    CrossrefPubMedGoogle Scholar
  • 5 Kaatz S, Douketis JD, Zhou H, Gage BF, White RH. Risk of stroke after surgery in patients with and without chronic atrial fibrillation. J Thromb Haemost 2010; 8 (5) 884-890
    PubMedGoogle Scholar
  • 6 Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 2010; 138 (5) 1093-1100
    CrossrefPubMedGoogle Scholar
  • 7 Omran H, Bauersachs R, Rübenacker S, Goss F, Hammerstingl C. The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation. Results from the national multicentre BNK Online bRiDging REgistRy (BORDER). Thromb Haemost 2012; 108 (1) 65-73
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Douketis JD, Spyropoulos AC, Spencer FA , et al. Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed. American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012; 141 (2 suppl.) 326-350
    CrossrefPubMedGoogle Scholar
  • 9 Nematulla A, Alabousi A, Blanas N, Douketis JD, Sutherland SE. Dental surgery for patients on anticoagulant therapy with warfarin: a systematic review and meta-analysis. J Can Dent Assoc 2009; 75 (1) 41
    PubMedGoogle Scholar
  • 10 Alcalay J. Cutaneous surgery in patients receiving warfarin therapy. Dermatol Surg 2001; 27 (8) 756-758
    CrossrefPubMedGoogle Scholar
  • 11 Billingsley EM, Maloney ME. Intraoperative and postoperative bleeding problems in patients taking warfarin, aspirin, and nonsteroidal antiinflammatory agents. A prospective study. Dermatol Surg 1997; 23 (5) 381-383 , discussion 384–385
    CrossrefPubMedGoogle Scholar
  • 12 Jamula E, Anderson J, Douketis JD. Safety of continuing warfarin therapy during cataract surgery: a systematic review and meta-analysis. Thromb Res 2009; 124 (3) 292-299
    CrossrefPubMedGoogle Scholar
  • 13 Kallio H, Paloheimo M, Maunuksela EL. Haemorrhage and risk factors associated with retrobulbar/peribulbar block: a prospective study in 1383 patients. Br J Anaesth 2000; 85 (5) 708-711
    CrossrefPubMedGoogle Scholar
  • 14 Palareti G, Legnani C. Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations. Clin Pharmacokinet 1996; 30 (4) 300-313
    CrossrefPubMedGoogle Scholar
  • 15 Ufer M. Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol. Clin Pharmacokinet 2005; 44 (12) 1227-1246
    CrossrefPubMedGoogle Scholar
  • 16 White RH, McKittrick T, Hutchinson R, Twitchell J. Temporary discontinuation of warfarin therapy: changes in the international normalized ratio. Ann Intern Med 1995; 122 (1) 40-42
    CrossrefPubMedGoogle Scholar
  • 17 Steib A, Barre J, Mertes M , et al. Can oral vitamin K before elective surgery substitute for preoperative heparin bridging in patients on vitamin K antagonists?. J Thromb Haemost 2010; 8 (3) 499-503
    CrossrefPubMedGoogle Scholar
  • 18 Dunn A. Perioperative management of oral anticoagulation: when and how to bridge. J Thromb Thrombolysis 2006; 21 (1) 85-89
    CrossrefPubMedGoogle Scholar
  • 19 Kovacs MJ, Kearon C, Rodger M , et al. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Circulation 2004; 110 (12) 1658-1663
    CrossrefPubMedGoogle Scholar
  • 20 Douketis JD, Johnson JA, Turpie AG. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. Arch Intern Med 2004; 164 (12) 1319-1326
    CrossrefPubMedGoogle Scholar
  • 21 Spyropoulos AC, Turpie AG, Dunn AS , et al; REGIMEN Investigators. Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry. J Thromb Haemost 2006; 4 (6) 1246-1252
    CrossrefPubMedGoogle Scholar
  • 22 Spandorfer JM, Lynch S, Weitz HH, Fertel S, Merli GJ. Use of enoxaparin for the chronically anticoagulated patient before and after procedures. Am J Cardiol 1999; 84 (4) 478-480 , A10
    CrossrefPubMedGoogle Scholar
  • 23 Constans M, Santamaria A, Mateo J, Pujol N, Souto JC, Fontcuberta J. Low-molecular-weight heparin as bridging therapy during interruption of oral anticoagulation in patients undergoing colonoscopy or gastroscopy. Int J Clin Pract 2007; 61 (2) 212-217
    CrossrefPubMedGoogle Scholar
  • 24 Pengo V, Cucchini U, Denas G , et al; Italian Federation of Centers for the Diagnosis of Thrombosis and Management of Antithrombotic Therapies (FCSA). Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study. Circulation 2009; 119 (22) 2920-2927
    CrossrefPubMedGoogle Scholar
  • 25 Malato A, Saccullo G, Lo Coco L , et al. Patients requiring interruption of long-term oral anticoagulant therapy: the use of fixed sub-therapeutic doses of low-molecular-weight heparin. J Thromb Haemost 2010; 8 (1) 107-113
    CrossrefPubMedGoogle Scholar
  • 26 Douketis JD, Woods K, Foster GA, Crowther MA. Bridging anticoagulation with low-molecular-weight heparin after interruption of warfarin therapy is associated with a residual anticoagulant effect prior to surgery. Thromb Haemost 2005; 94 (3) 528-531
    PubMedGoogle Scholar
  • 27 Dunn AS, Spyropoulos AC, Turpie AG. Bridging therapy in patients on long-term oral anticoagulants who require surgery: the Prospective Peri-operative Enoxaparin Cohort Trial (PROSPECT). J Thromb Haemost 2007; 5 (11) 2211-2218
    CrossrefPubMedGoogle Scholar
  • 28 Devereaux PJ, Chan M, Eikelboom J. Major vascular complications in patients undergoing non-cardiac surgery: magnitude of the problem, risk prediction, surveillance, and prevention. In: Yusuf S, Cairns JA, Camm AJ, Fallen EL, Gersh BJ, , editors. Evidence based Cardiology. 3rd ed. West Sussex, UK: Wiley-Blackwell; 2010: 47-62
    Google Scholar
  • 29 Priebe HJ. Triggers of perioperative myocardial ischaemia and infarction. Br J Anaesth 2004; 93 (1) 9-20
    CrossrefPubMedGoogle Scholar
  • 30 Devereaux PJ, Goldman L, Cook DJ, Gilbert K, Leslie K, Guyatt GH. Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. CMAJ 2005; 173 (6) 627-634
    CrossrefPubMedGoogle Scholar
  • 31 Yun AJ, Lee PY, Bazar KA. Can thromboembolism be the result, rather than the inciting cause, of acute vascular events such as stroke, pulmonary embolism, mesenteric ischemia, and venous thrombosis?: a maladaptation of the prehistoric trauma response. Med Hypotheses 2005; 64 (4) 706-716
    CrossrefPubMedGoogle Scholar
  • 32 Hjemdahl P, Larsson PT, Wallén NH. Effects of stress and beta-blockade on platelet function. Circulation 1991; 84 (6, Suppl) VI44-VI61
    PubMedGoogle Scholar
  • 33 Beving H, Zhao C, Albåge A, Ivert T. Abnormally high platelet activity after discontinuation of acetylsalicylic acid treatment. Blood Coagul Fibrinolysis 1996; 7 (1) 80-84
    CrossrefPubMedGoogle Scholar
  • 34 Fatah K, Beving H, Albåge A, Ivert T, Blombäck M. Acetylsalicylic acid may protect the patient by increasing fibrin gel porosity. Is withdrawing of treatment harmful to the patient?. Eur Heart J 1996; 17 (9) 1362-1366
    CrossrefPubMedGoogle Scholar
  • 35 Biondi-Zoccai GG, Lotrionte M, Agostoni P , et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J 2006; 27 (22) 2667-2674
    CrossrefPubMedGoogle Scholar
  • 36 Mantz J, Samama CM, Tubach F , et al; Stratagem Study Group. Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective non-cardiac surgery: the multicentre, randomized, blinded, placebo-controlled, STRATAGEM trial. Br J Anaesth 2011; 107 (6) 899-910
    CrossrefPubMedGoogle Scholar
  • 37 Oscarsson A, Gupta A, Fredrikson M , et al. To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial. Br J Anaesth 2010; 104 (3) 305-312
    CrossrefPubMedGoogle Scholar
  • 38 Pulmonary Embolism Prevention (PEP) Trial Collaborative Group. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 2000; 355 (9212) 1295-1302
    CrossrefPubMedGoogle Scholar
  • 39 Burger W, Chemnitius JM, Kneissl GD, Rücker G. Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation – review and meta-analysis. J Intern Med 2005; 257 (5) 399-414
    CrossrefPubMedGoogle Scholar
  • 40 Palmer JD, Sparrow OC, Iannotti F. Postoperative hematoma: a 5-year survey and identification of avoidable risk factors. Neurosurgery 1994; 35 (6) 1061-1064 , discussion 1064–1065
    CrossrefPubMedGoogle Scholar
  • 41 Reddy PR, Vaitkus PT. Risks of noncardiac surgery after coronary stenting. Am J Cardiol 2005; 95 (6) 755-757
    CrossrefPubMedGoogle Scholar
  • 42 Ernst A, Eberhardt R, Wahidi M, Becker HD, Herth FJ. Effect of routine clopidogrel use on bleeding complications after transbronchial biopsy in humans. Chest 2006; 129 (3) 734-737
    CrossrefPubMedGoogle Scholar
  • 43 Sørensen R, Hansen ML, Abildstrom SZ , et al. Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data. Lancet 2009; 374 (9706) 1967-1974
    CrossrefPubMedGoogle Scholar
  • 44 Roger VL, Go AS, Lloyd-Jones DM , et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2011 update: a report from the American Heart Association. Circulation 2011; 123 (4) e18-e209
    CrossrefPubMedGoogle Scholar
  • 45 To AC, Armstrong G, Zeng I, Webster MWI. Noncardiac surgery and bleeding after percutaneous coronary intervention. Circ Cardiovasc Interv 2009; 2 (3) 213-221
    CrossrefPubMedGoogle Scholar
  • 46 Vicenzi MN, Meislitzer T, Heitzinger B, Halaj M, Fleisher LA, Metzler H. Coronary artery stenting and non-cardiac surgery—a prospective outcome study. Br J Anaesth 2006; 96 (6) 686-693
    CrossrefPubMedGoogle Scholar
  • 47 Compton PA, Zankar AA, Adesanya AO, Banerjee S, Brilakis ES. Risk of noncardiac surgery after coronary drug-eluting stent implantation. Am J Cardiol 2006; 98 (9) 1212-1213
    CrossrefPubMedGoogle Scholar
  • 48 Rabbitts JA, Nuttall GA, Brown MJ , et al. Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents. Anesthesiology 2008; 109 (4) 596-604
    CrossrefPubMedGoogle Scholar
  • 49 Fox KA, Mehta SR, Peters RJ , et al; Clopidogrel in unstable angina to prevent recurrent ischemic events trial—benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome—the clopidogrel in unstable angina to prevent recurrent ischemic events (CURE) trial. Circulation 2004; 110 (10) 1202-1208
    CrossrefPubMedGoogle Scholar
  • 50 Robless P, Mikhailidis DP, Stansby G. Systematic review of antiplatelet therapy for the prevention of myocardial infarction, stroke or vascular death in patients with peripheral vascular disease. Br J Surg 2001; 88 (6) 787-800
    CrossrefPubMedGoogle Scholar
  • 51 Bell AD, Roussin A, Cartier R , et al; Canadian Cardiovascular Society. The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society guidelines. Can J Cardiol 2011; 27 (Suppl A) S1-S59
    CrossrefPubMedGoogle Scholar
  • 52 Ong ATL, McFadden EP, Regar E, de Jaegere PP, van Domburg RT, Serruys PW. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 2005; 45 (12) 2088-2092
    CrossrefPubMedGoogle Scholar
  • 53 Iakovou I, Schmidt T, Bonizzoni E , et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293 (17) 2126-2130
    CrossrefPubMedGoogle Scholar
  • 54 Nuttall GA, Brown MJ, Stombaugh JW , et al. Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention. Anesthesiology 2008; 109 (4) 588-595
    CrossrefPubMedGoogle Scholar
  • 55 Abualsaud AO, Eisenberg MJ. Perioperative management of patients with drug-eluting stents. JACC Cardiovasc Interv 2010; 3 (2) 131-142
    CrossrefPubMedGoogle Scholar
  • 56 Cruden NL, Harding SA, Flapan AD , et al; Scottish Coronary Revascularisation Register Steering Committee. Previous coronary stent implantation and cardiac events in patients undergoing noncardiac surgery. Circ Cardiovasc Interv 2010; 3 (3) 236-242
    CrossrefPubMedGoogle Scholar
  • 57 Thiele T, Sümnig A, Hron G , et al. Platelet transfusion for reversal of dual antiplatelet therapy in patients requiring urgent surgery: a pilot study. J Thromb Haemost 2012; 10 (5) 968-971
    CrossrefPubMedGoogle Scholar
  • 58 Madan GA, Madan SG, Madan G, Madan AD. Minor oral surgery without stopping daily low-dose aspirin therapy: a study of 51 patients. J Oral Maxillofac Surg 2005; 63 (9) 1262-1265
    CrossrefPubMedGoogle Scholar
  • 59 Kargi E, Babuccu O, Hosnuter M, Babuccu B, Altinyazar C. Complications of minor cutaneous surgery in patients under anticoagulant treatment. Aesthetic Plast Surg 2002; 26 (6) 483-485
    CrossrefPubMedGoogle Scholar
  • 60 Lumme P, Laatikainen LT. Risk factors for intraoperative and early postoperative complications in extracapsular cataract surgery. Eur J Ophthalmol 1994; 4 (3) 151-158
    PubMedGoogle Scholar
  • 61 Kumar N, Jivan S, Thomas P, McLure H. Sub-Tenon's anesthesia with aspirin, warfarin, and clopidogrel. J Cataract Refract Surg 2006; 32 (6) 1022-1025
    CrossrefPubMedGoogle Scholar
  • 62 Patrono C, Baigent C, Hirsh J , et al. Antiplatelet drugs: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 2008; 133 (6 Suppl) 199-233
    CrossrefPubMedGoogle Scholar
  • 63 Bolsin S, Conroy M, Osborne C. Tirofiban 'bridging' therapy for patients with drug-eluting stents undergoing non-cardiac surgery. Br J Anaesth 2010; 104 (6) 779-780 , author reply 779–780
    CrossrefPubMedGoogle Scholar
  • 64 Angiolillo DJ, Firstenberg MS, Price MJ , et al; BRIDGE Investigators. Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial. JAMA 2012; 307 (3) 265-274
    CrossrefPubMedGoogle Scholar